Amicus Therapeutics rare disease drug effective in trial

April 29, 2014 6:50 PM

15 0

(Reuters) - Amicus Therapeutics Inc said its experimental drug significantly reduced the abnormal accumulation of fat in body cells related to a rare genetic disorder that could lead to heart attack, stroke and kidney failure.

The company, whose shares rose as much as 36 percent, said it would file for U.S. marketing approval based on these results and those from an European trial, expected in the third quarter.

Read more

To category page